Table 4.
Frequency distribution of more common adverse events and serious adverse events in persons with relapsing remitting multiple sclerosis treated with dimethyl fumarate.
Dimethyl fumarate | 62 (26.5), No. (%) | |
---|---|---|
Adverse events | Flushing, itch | 31 (13.3) |
Diarrhea, colitis | 11 (5.6) | |
Epigastralgia, nausea | 9 (3.8) | |
Lymphopenia | 3 (2.1) | |
Increase of transaminases | 2 (0.9) | |
Herpes zoster reactivation | 1 (0.4) | |
Depression | 1 (0.4) | |
Serious adverse events | Severe lymphopenia | 2 (0.9) |
Severe diarrhea | 2 (0.9) |